Noticias

Compartir en Facebook Compartir en Twiter Compartir en Menéame Compartir en Linkedin Suscribirse a nuestra RSS

Un estudio apunta los beneficios del cannabis para tratar la fibromialgia

acbd.com/" title="" target="">CBD per dose.

The patients were separated into two groups, one of which received the cannabis oil, while the members of the control group received a placebo. The Fibromyalgia Impact Questionnaire (FIQ) was administered before and after the intervention and at five visits over eight weeks. The researchers reported that “the impact of the intervention on the quality of life of participants in the cannabis group was evident, resulting in reports of well-being and more energy for activities of daily living. Pain attacks were also reduced. "

"To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil, a whole plant extract rich in THC, on the symptoms and quality of life of people with fibromyalgia," the researchers wrote. “We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and improvement of quality of life in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system ”.

Due to the impact fibromyalgia can have on patients" health and the need for effective and affordable medications to treat them, the researchers recommended further research to study cannabis as a treatment for the condition.

“Considering the far-reaching harm caused by FM and the effect it can have on individuals, their families, communities, and the public health system, it seems necessary to study low-cost, well-tolerated alternative therapies that help patients to recover their well-being and quality of life, "he wrote. "The present study aims to evaluate the impact that cannabis oil, a whole plant extract rich in THC, can have on the symptoms and quality of life of people affected by FM."

Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws (NORML), commented on the investigation in a statement from the group on Friday.

"The demonstration of safety and efficacy in this gold standard model is significant," Armentano said. “Millions of Americans have FM, a condition that tends to be poorly controlled with standard medications. These clinical findings indicate that for many of these patients, plant-derived cannabis preparations may be a safe and effective alternative. "